Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7962680rdf:typepubmed:Citationlld:pubmed
pubmed-article:7962680lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C0009010lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C0028768lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C0026777lld:lifeskim
pubmed-article:7962680lifeskim:mentionsumls-concept:C0206012lld:lifeskim
pubmed-article:7962680pubmed:issue4lld:pubmed
pubmed-article:7962680pubmed:dateCreated1994-12-12lld:pubmed
pubmed-article:7962680pubmed:abstractTextThere have been many attempts to find predictors of the therapeutic response to the clomipramine treatment of obsessive-compulsive disorder. The majority of studies have failed to identify such predictors. Possible reasons for this failure include the small sample size of most studies, samples homogeneous with respect to the study factors of interest, and the use of statistical procedures that are insensitive to individual differences or that inadequately control for confounding. We have reanalyzed data from Ciba-Geigy's large, multicenter clinical trial of clomipramine for obsessive-compulsive disorder, using stratification and regression techniques to identify multiple prognostic factors and control for confounders. We assessed the relationship between therapeutic response and baseline measures such as severity of symptoms, type of symptoms (obsessions, compulsions, depression), length of illness, age of onset, and other demographic factors (age, race, and sex). We found age of onset to be a strong predictor of response to clomipramine: people who develop obsessive-compulsive disorder later in life have a better chance of responding than do those who become ill earlier, independent of length of illness. We also found that baseline depression is associated with response, but the association appears to be nonlinear.lld:pubmed
pubmed-article:7962680pubmed:languageenglld:pubmed
pubmed-article:7962680pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962680pubmed:citationSubsetIMlld:pubmed
pubmed-article:7962680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962680pubmed:statusMEDLINElld:pubmed
pubmed-article:7962680pubmed:monthAuglld:pubmed
pubmed-article:7962680pubmed:issn0271-0749lld:pubmed
pubmed-article:7962680pubmed:authorpubmed-author:KatzR JRJlld:pubmed
pubmed-article:7962680pubmed:authorpubmed-author:MorgensternHHlld:pubmed
pubmed-article:7962680pubmed:authorpubmed-author:GreenlandSSlld:pubmed
pubmed-article:7962680pubmed:authorpubmed-author:BystritskyAAlld:pubmed
pubmed-article:7962680pubmed:authorpubmed-author:AckermanD LDLlld:pubmed
pubmed-article:7962680pubmed:issnTypePrintlld:pubmed
pubmed-article:7962680pubmed:volume14lld:pubmed
pubmed-article:7962680pubmed:ownerNLMlld:pubmed
pubmed-article:7962680pubmed:authorsCompleteYlld:pubmed
pubmed-article:7962680pubmed:pagination247-54lld:pubmed
pubmed-article:7962680pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:meshHeadingpubmed-meshheading:7962680-...lld:pubmed
pubmed-article:7962680pubmed:year1994lld:pubmed
pubmed-article:7962680pubmed:articleTitlePredictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.lld:pubmed
pubmed-article:7962680pubmed:affiliationDepartment of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine.lld:pubmed
pubmed-article:7962680pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7962680pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7962680pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:7962680pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7962680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7962680lld:pubmed